182 related articles for article (PubMed ID: 1973944)
21. Treating the anxiety: therapeutic options in obsessive compulsive disorder.
Greist JH
J Clin Psychiatry; 1990 Nov; 51 Suppl():29-34. PubMed ID: 2146255
[TBL] [Abstract][Full Text] [Related]
22. Clomipramine use in obsessive-compulsive disorder.
Ivey JL; Rosenberg DR
Expert Rev Neurother; 2002 Nov; 2(6):783-90. PubMed ID: 19810911
[TBL] [Abstract][Full Text] [Related]
23. A double-blind study of adjuvant buspirone hydrochloride in clomipramine-treated patients with obsessive-compulsive disorder.
Pigott TA; L'Heureux F; Hill JL; Bihari K; Bernstein SE; Murphy DL
J Clin Psychopharmacol; 1992 Feb; 12(1):11-8. PubMed ID: 1552034
[TBL] [Abstract][Full Text] [Related]
24. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
Pigott TA; Seay SM
J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636
[TBL] [Abstract][Full Text] [Related]
25. [Psychobiology of compulsive disease].
Lesch KP
Fortschr Neurol Psychiatr; 1991 Oct; 59(10):404-12. PubMed ID: 1761269
[TBL] [Abstract][Full Text] [Related]
26. Pharmacologic therapy of obsessive compulsive disorder.
DeVeaugh-Geiss J
Adv Pharmacol; 1994; 30():35-52. PubMed ID: 7833296
[TBL] [Abstract][Full Text] [Related]
27. Psychopharmacologic treatment of child and adolescent obsessive compulsive disorder.
Piacentini J; Jaffer M; Gitow A; Graae F; Davies SO; Del Bene D; Liebowitz M
Psychiatr Clin North Am; 1992 Mar; 15(1):87-107. PubMed ID: 1549550
[TBL] [Abstract][Full Text] [Related]
28. A case report of refractory obsessive-compulsive disorder improved by risperidone augmentation of clomipramine treatment.
Kawahara T; Ueda Y; Mitsuyama Y
Psychiatry Clin Neurosci; 2000 Oct; 54(5):599-601. PubMed ID: 11043813
[TBL] [Abstract][Full Text] [Related]
29. Buspirone in obsessive-compulsive disorder.
Maruno CA; Hart LL
Ann Pharmacother; 1992 Oct; 26(10):1248-51. PubMed ID: 1421651
[No Abstract] [Full Text] [Related]
30. Intravenous anti-obsessive agents: a review.
Ravindran LN; Jung SM; Ravindran AV
J Psychopharmacol; 2010 Mar; 24(3):287-96. PubMed ID: 18801828
[TBL] [Abstract][Full Text] [Related]
31. Serotonin and effect sizes of antiobsessive agents.
Pato MT; Gluhoski V
Am J Psychiatry; 1992 Mar; 149(3):420-1. PubMed ID: 1531582
[No Abstract] [Full Text] [Related]
32. The pharmacotherapy of obsessive-compulsive disorder.
McDougle CJ; Goodman WK; Price LH
Pharmacopsychiatry; 1993 May; 26 Suppl 1():24-9. PubMed ID: 8378419
[TBL] [Abstract][Full Text] [Related]
33. Double-blind comparison of fluoxetine versus clomipramine in the treatment of obsessive compulsive disorder.
López-Ibor JJ; Saiz J; Cottraux J; Note I; Viñas R; Bourgeois M; Hernández M; Gómez-Pérez JC
Eur Neuropsychopharmacol; 1996 May; 6(2):111-8. PubMed ID: 8791036
[TBL] [Abstract][Full Text] [Related]
34. Pharmacotherapy for obsessive-compulsive disorder.
Hollander E; Kaplan A; Allen A; Cartwright C
Psychiatr Clin North Am; 2000 Sep; 23(3):643-56. PubMed ID: 10986733
[TBL] [Abstract][Full Text] [Related]
35. Treatment of obsessive-compulsive disorder using clomipramine in a very old patient.
Trappler B
Ann Pharmacother; 1999 Jun; 33(6):686-90. PubMed ID: 10410180
[TBL] [Abstract][Full Text] [Related]
36. A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.
Carpenter LL; McDougle CJ; Epperson CN; Price LH
Drug Saf; 1996 Aug; 15(2):116-34. PubMed ID: 8884163
[TBL] [Abstract][Full Text] [Related]
37. Azapirones: history of development.
Eison AS
J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):2S-5S. PubMed ID: 1973936
[TBL] [Abstract][Full Text] [Related]
38. Sertraline in obsessive-compulsive disorder: a double-blind comparison with placebo.
Jenike MA; Baer L; Summergrad P; Minichiello WE; Holland A; Seymour R
Am J Psychiatry; 1990 Jul; 147(7):923-8. PubMed ID: 2192564
[TBL] [Abstract][Full Text] [Related]
39. OCD: where the serotonin selectivity story begins.
Pigott TA
J Clin Psychiatry; 1996; 57 Suppl 6():11-20. PubMed ID: 8647793
[TBL] [Abstract][Full Text] [Related]
40. Double-blind study of adjuvant buspirone for fluoxetine-treated patients with obsessive-compulsive disorder.
Grady TA; Pigott TA; L'Heureux F; Hill JL; Bernstein SE; Murphy DL
Am J Psychiatry; 1993 May; 150(5):819-21. PubMed ID: 8480832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
